{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T09:27:25Z","timestamp":1786526845015,"version":"build-2736575974"},"reference-count":59,"publisher":"MDPI AG","issue":"16","license":[{"start":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:00:00Z","timestamp":1786492800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Fondazione Giovanni Celeghin"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biology"],"abstract":"<jats:p>This study reports the design, synthesis, and biological evaluation of novel inhibitors targeting the epigenetic enzymes ALKBH2 and ALKBH5 as potential adjuvants to temozolomide therapy in glioblastoma. Given their critical role in DNA\/RNA demethylation, tumor progression, and drug resistance, their inhibition represents a promising therapeutic strategy. Building on the previously identified lead compound MV1035, we employed structure-based drug design to develop new derivatives, including a second-generation series incorporating a fumarate hydrazide moiety to enhance binding affinity through interaction with both substrate- and cofactor-binding sites. Molecular docking studies predicted significantly improved binding for a set of new compounds but, due to multiple synthetic drawbacks, only a subset of the designed series was synthesized and evaluated biologically. MV3030 emerged as the most promising candidate. MV3030 demonstrated an inhibitory effect on ALKBH2 comparable to MV1035, also showing a more moderate inhibitory effect on ALKBH5. Notably, it exhibited intrinsic cytotoxicity in U87-MG cells and patient-derived glioma stem cells, whereas normal astrocytes exhibited markedly higher resistance to the treatment. Furthermore, MV3030 enhanced temozolomide efficacy and displayed favorable blood\u2013brain barrier permeability both in silico and in vitro. Moreover, MV3030 modulated the FoxM1\/Wnt\/\u03b2-catenin axis. Overall, these findings identify MV3030 as a promising compound with the potential to overcome temozolomide resistance and improve glioblastoma treatment.<\/jats:p>","DOI":"10.3390\/biology15161371","type":"journal-article","created":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T07:57:26Z","timestamp":1786521446000},"page":"1371","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Design and Biological Evaluation of ALKBH2 and ALKBH5 Inhibitors as Adjuvants to Temozolomide-Based Glioblastoma Treatment"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6809-0020","authenticated-orcid":false,"given":"Mirko","family":"Rivara","sequence":"first","affiliation":[{"name":"Food and Drug Department, University of Parma, Parco Area delle Scienze 27\/A, 43124 Parma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessio","family":"Malacrida","sequence":"additional","affiliation":[{"name":"Experimental Neurology Unit, School of Medicine and Surgery, University of Milano-Bicocca, Via Cadore 48, 20900 Monza, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-4982-7182","authenticated-orcid":false,"given":"Martina","family":"Ghizzi","sequence":"additional","affiliation":[{"name":"School of Medicine and Surgery, University of Milano-Bicocca, Via Cadore 48, 20900 Monza, Italy"},{"name":"PhD Program in Neuroscience, School of Medicine and Surgery, University of Milano-Bicocca, 20900 Monza, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7535-846X","authenticated-orcid":false,"given":"Angela","family":"Bentivegna","sequence":"additional","affiliation":[{"name":"School of Medicine and Surgery, University of Milano-Bicocca, Via Cadore 48, 20900 Monza, Italy"},{"name":"Fondazione IRCCS San Gerardo dei Tintori, 20900 Monza, Italy"},{"name":"GBM-BI-TRACE (GlioBlastoMa-BIcocca-TRAnslational-CEnter), University of Milano-Bicocca, 20900 Monza, Italy"},{"name":"Inter-University Center for the Promotion of the 3Rs Principles in Teaching & Research (Centro 3R), 56122 Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco Saverio","family":"Sica","sequence":"additional","affiliation":[{"name":"School of Medicine and Surgery, University of Milano-Bicocca, Via Cadore 48, 20900 Monza, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1374-567X","authenticated-orcid":false,"given":"Francesca","family":"Re","sequence":"additional","affiliation":[{"name":"School of Medicine and Surgery, University of Milano-Bicocca, Via Cadore 48, 20900 Monza, Italy"},{"name":"Fondazione IRCCS San Gerardo dei Tintori, 20900 Monza, Italy"},{"name":"GBM-BI-TRACE (GlioBlastoMa-BIcocca-TRAnslational-CEnter), University of Milano-Bicocca, 20900 Monza, Italy"},{"name":"Inter-University Center for the Promotion of the 3Rs Principles in Teaching & Research (Centro 3R), 56122 Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0812-6834","authenticated-orcid":false,"given":"Stefano","family":"Motta","sequence":"additional","affiliation":[{"name":"Inter-University Center for the Promotion of the 3Rs Principles in Teaching & Research (Centro 3R), 56122 Pisa, Italy"},{"name":"Department of Earth and Environmental Sciences, University of Milano-Bicocca, Piazza della Scienza 1, 20126 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lara","family":"Callea","sequence":"additional","affiliation":[{"name":"Department of Earth and Environmental Sciences, University of Milano-Bicocca, Piazza della Scienza 1, 20126 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3028-0368","authenticated-orcid":false,"given":"Laura","family":"Bonati","sequence":"additional","affiliation":[{"name":"Department of Earth and Environmental Sciences, University of Milano-Bicocca, Piazza della Scienza 1, 20126 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Incerti","sequence":"additional","affiliation":[{"name":"Food and Drug Department, University of Parma, Parco Area delle Scienze 27\/A, 43124 Parma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2242-3317","authenticated-orcid":false,"given":"Valentina","family":"Zuliani","sequence":"additional","affiliation":[{"name":"Food and Drug Department, University of Parma, Parco Area delle Scienze 27\/A, 43124 Parma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6241-4538","authenticated-orcid":false,"given":"Gabriella","family":"Nicolini","sequence":"additional","affiliation":[{"name":"Experimental Neurology Unit, School of Medicine and Surgery, University of Milano-Bicocca, Via Cadore 48, 20900 Monza, Italy"},{"name":"GBM-BI-TRACE (GlioBlastoMa-BIcocca-TRAnslational-CEnter), University of Milano-Bicocca, 20900 Monza, Italy"},{"name":"Inter-University Center for the Promotion of the 3Rs Principles in Teaching & Research (Centro 3R), 56122 Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,12]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Sadowski, K., Ja\u017cd\u017cewska, A., Koz\u0142owski, J., Zacny, A., Lorenc, T., and Olejarz, W. (2024). Revolutionizing Glioblastoma Treatment: A Comprehensive Overview of Modern Therapeutic Approaches. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25115774"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Tang, J., Karbhari, N., and Campian, J.L. (2025). Therapeutic Targets in Glioblastoma: Molecular Pathways, Emerging Strategies, and Future Directions. Cells, 14.","DOI":"10.20944\/preprints202502.1189.v1"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1002\/1878-0261.13706","article-title":"Unravelling the Mosaic: Epigenetic Diversity in Glioblastoma","volume":"18","author":"Lucchini","year":"2024","journal-title":"Mol. Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1080\/17460441.2025.2582541","article-title":"Recent Advances in the Discovery of ALKBH 1\u20138 Inhibitors","volume":"20","author":"Silva","year":"2025","journal-title":"Expert. Opin. Drug Discov."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"115300","DOI":"10.1016\/j.bmc.2019.115300","article-title":"3D Proteome-Wide Scale Screening and Activity Evaluation of a New ALKBH5 Inhibitor in U87 Glioblastoma Cell Line","volume":"28","author":"Malacrida","year":"2020","journal-title":"Bioorg. Med. Chem."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Malacrida, A., Di Domizio, A., Bentivegna, A., Cislaghi, G., Messuti, E., Tabano, S.M., Giussani, C., Zuliani, V., Rivara, M., and Nicolini, G. (2022). MV1035 Overcomes Temozolomide Resistance in Patient-Derived Glioblastoma Stem Cell Lines. Biology, 11.","DOI":"10.3390\/biology11010070"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"101645","DOI":"10.1016\/j.rechem.2024.101645","article-title":"New ALKBH2 and ALKBH5 Inhibitors for Treating Glioblastoma","volume":"9","author":"Rivara","year":"2024","journal-title":"Results Chem."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nsmb.2320","article-title":"Duplex Interrogation by a Direct DNA Repair Protein in Search of Base Damage","volume":"19","author":"Yi","year":"2012","journal-title":"Nat. Struct. Mol. Biol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"4148","DOI":"10.1093\/nar\/gkac195","article-title":"Mechanisms of Substrate Recognition and N 6-Methyladenosine Demethylation Revealed by Crystal Structures of ALKBH5\u2013RNA Complexes","volume":"50","author":"Kaur","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s10822-013-9644-8","article-title":"Protein and Ligand Preparation: Parameters, Protocols, and Influence on Virtual Screening Enrichments","volume":"27","author":"Sastry","year":"2013","journal-title":"J. Comput. Aided Mol. Des."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1021\/ct200133y","article-title":"Improved Treatment of Ligands and Coupling Effects in Empirical Calculation and Rationalization of pKa Values","volume":"7","author":"Olsson","year":"2011","journal-title":"J. Chem. Theory Comput."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s10822-007-9133-z","article-title":"Epik: A Software Program for pK(a) Prediction and Protonation State Generation for Drug-like Molecules","volume":"21","author":"Shelley","year":"2007","journal-title":"J. Comput. Aided Mol. Des."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"6177","DOI":"10.1021\/jm051256o","article-title":"Extra Precision Glide: Docking and Scoring Incorporating a Model of Hydrophobic Enclosure for Protein-Ligand Complexes","volume":"49","author":"Friesner","year":"2006","journal-title":"J. Med. Chem."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1021\/cn100008c","article-title":"Moving beyond rules: The Development of a Central Nervous System Multiparameter Optimization (CNS MPO) Approach to Enable Alignment of Druglike Properties","volume":"1","author":"Wager","year":"2010","journal-title":"ACS Chem. Neurosci."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1021\/acschemneuro.6b00029","article-title":"Central Nervous System Multiparameter Optimization Desirability: Application in Drug Discovery","volume":"7","author":"Wager","year":"2016","journal-title":"ACS Chem. Neurosci."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1039\/D4NR03174A","article-title":"Nanoparticle Shape Is the Game-Changer for Blood-Brain Barrier Crossing and Delivery Through Tunneling Nanotubes among Glioblastoma Cells","volume":"17","author":"Sierri","year":"2025","journal-title":"Nanoscale"},{"key":"ref_17","first-page":"1335","article-title":"Effect of Nanoparticles Binding \u03b2-Amyloid Peptide on Nitric Oxide Production by Cultured Endothelial Cells and Macrophages","volume":"8","author":"Orlando","year":"2013","journal-title":"Int. J. Nanomed."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.stem.2009.03.014","article-title":"Glioma Stem Cell Lines Expanded in Adherent Culture Have Tumor-Specific Phenotypes and Are Suitable for Chemical and Genetic Screens","volume":"4","author":"Pollard","year":"2009","journal-title":"Cell Stem Cell"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Giambra, M., Messuti, E., Di Cristofori, A., Cavandoli, C., Bruno, R., Buonanno, R., Marzorati, M., Zambuto, M., Rodriguez-Menendez, V., and Redaelli, S. (2021). Characterizing the Genomic Profile in High-Grade Gliomas: From Tumor Core to Peritumoral Brain Zone, Passing through Glioma-Derived Tumorspheres. Biology, 10.","DOI":"10.3390\/biology10111157"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Baronchelli, S., Bentivegna, A., Redaelli, S., Riva, G., Butta, V., Paoletta, L., Isimbaldi, G., Miozzo, M., Tabano, S., and Daga, A. (2013). Delineating the Cytogenomic and Epigenomic Landscapes of Glioma Stem Cell Lines. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0057462"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jim.2009.06.008","article-title":"ELDA: Extreme Limiting Dilution Analysis for Comparing Depleted and Enriched Populations in Stem Cell and Other Assays","volume":"347","author":"Hu","year":"2009","journal-title":"J. Immunol. Methods"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1039\/C4SC02554G","article-title":"A Strategy Based on Nucleotide Specificity Leads to a Subfamily-Selective and Cell-Active Inhibitor of N6 -Methyladenosine Demethylase FTO","volume":"6","author":"Toh","year":"2015","journal-title":"Chem. Sci."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"4551","DOI":"10.1021\/jo070187d","article-title":"A Practical Synthesis of 2,4(5)-Diarylimidazoles from Simple Building Blocks","volume":"72","author":"Zuliani","year":"2007","journal-title":"J. Org. Chem."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1021\/ml300322n","article-title":"Discovery of a Series of Thiazole Derivatives as Novel Inhibitors of Metastatic Cancer Cell Migration and Invasion","volume":"4","author":"Zheng","year":"2013","journal-title":"ACS Med. Chem. Lett."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1039\/C2OB26648B","article-title":"Dual-Action Inhibitors of HIF Prolyl Hydroxylases That Induce Binding of a Second Iron Ion","volume":"11","author":"Yeoh","year":"2013","journal-title":"Org. Biomol. Chem."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"3994","DOI":"10.3390\/curroncol31070296","article-title":"Temozolomide (TMZ) in the Treatment of Glioblastoma Multiforme-A Literature Review and Clinical Outcomes","volume":"31","author":"Nafalska","year":"2024","journal-title":"Curr. Oncol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ejpb.2019.06.004","article-title":"Protein-Functionalized Nanoparticles Derived from End-Functional Polymers and Polymer Prodrugs for Crossing the Blood-Brain Barrier","volume":"142","author":"Cox","year":"2019","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"37437","DOI":"10.1038\/s41598-025-21272-3","article-title":"Modulation of the Blood-Brain Barrier Permeability by Patient-Derived Glioblastoma Stem Cell Secretome","volume":"15","author":"Sica","year":"2025","journal-title":"Sci. Rep."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1096\/fj.04-3458fje","article-title":"Blood-Brain Barrier-Specific Properties of a Human Adult Brain Endothelial Cell Line","volume":"19","author":"Weksler","year":"2005","journal-title":"FASEB J."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.2217\/nnm-2020-0132","article-title":"An Update of Nanoparticle-Based Approaches for Glioblastoma Multiforme Immunotherapy","volume":"15","author":"Taiarol","year":"2020","journal-title":"Nanomedicine"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.mvr.2008.08.004","article-title":"Non-Invasive Measurement of Solute Permeability in Cerebral Microvessels of the Rat","volume":"77","author":"Yuan","year":"2009","journal-title":"Microvasc. Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s12987-025-00726-w","article-title":"Comparative analysis of the Uptake of The H+\/OC Antiporter Substrate Oxycodone Across and into Brain Endothelial and Parenchymal Cells with in Vitro-in Vivo Extrapolation","volume":"22","author":"Svane","year":"2025","journal-title":"Fluids Barriers CNS"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"163767","DOI":"10.1016\/j.scitotenv.2023.163767","article-title":"Predicting Human Neurotoxicity of Propylene Glycol Methyl Ether (PGME) by Implementing in Vitro Neurotoxicity Results into Toxicokinetic Modelling","volume":"886","author":"Reale","year":"2023","journal-title":"Sci. Total Environ."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s12987-020-00198-0","article-title":"Development of a Human in Vitro Blood-Brain Tumor Barrier Model of Diffuse Intrinsic Pontine Glioma to Better Understand the Chemoresistance","volume":"17","author":"Deligne","year":"2020","journal-title":"Fluids Barriers CNS"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.ccr.2006.03.030","article-title":"Tumor Stem Cells Derived from Glioblastomas Cultured in bFGF and EGF More Closely Mirror the Phenotype and Genotype of Primary Tumors than Do Serum-Cultured Cell Lines","volume":"9","author":"Lee","year":"2006","journal-title":"Cancer Cell"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.ccell.2017.02.013","article-title":"m6A Demethylase ALKBH5 Maintains Tumorigenicity of Glioblastoma Stem-like Cells by Sustaining FOXM1 Expression and Cell Proliferation Program","volume":"31","author":"Zhang","year":"2017","journal-title":"Cancer Cell"},{"key":"ref_37","first-page":"e23155","article-title":"Exploring the Role of m6A Methylation Regulators in Glioblastoma Multiforme and Their Impact on the Tumor Immune Microenvironment","volume":"37","author":"Deng","year":"2023","journal-title":"FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1038\/s41598-024-51994-9","article-title":"ALKBH5 is a Prognostic Factor and Promotes The Angiogenesis of Glioblastoma","volume":"14","author":"Fan","year":"2024","journal-title":"Sci. Rep."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Feng, S., Xu, Z., Peng, J., and Zhang, M. (2022). The AlkB Family: Potential Prognostic Biomarkers and Therapeutic Targets in Glioblastoma. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.847821"},{"key":"ref_40","first-page":"195","article-title":"The Role of ALKBH5 in Regulating Proliferation and Invasion in U251 Glioblastoma Cells","volume":"29","author":"Jamali","year":"2025","journal-title":"Contemp. Oncol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1093\/neuonc\/nos301","article-title":"The DNA Repair Protein ALKBH2 Mediates Temozolomide Resistance in Human Glioblastoma Cells","volume":"15","author":"Johannessen","year":"2013","journal-title":"Neuro Oncol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"117054","DOI":"10.1016\/j.ejmech.2024.117054","article-title":"Discovery and Structure-Activity Relationship Study of Nicotinamide Derivatives as DNA Demethylase ALKBH2 Inhibitors","volume":"282","author":"Xu","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"a012575","DOI":"10.1101\/cshperspect.a012575","article-title":"DNA Repair by Reversal of DNA Damage","volume":"5","author":"Yi","year":"2013","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"5522","DOI":"10.1093\/nar\/gkz395","article-title":"DNA Repair Enzymes ALKBH2, ALKBH3, and AlkB Oxidize 5-Methylcytosine to 5-Hydroxymethylcytosine, 5-Formylcytosine and 5-Carboxylcytosine in Vitro","volume":"47","author":"Bian","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Dong, Z., and Cui, H. (2020). The Emerging Roles of RNA Modifications in Glioblastoma. Cancers, 12.","DOI":"10.3390\/cancers12030736"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1038\/s41419-018-1084-x","article-title":"MINA53 Deficiency Leads to Glioblastoma Cell Apoptosis via Inducing DNA Replication Stress and Diminishing DNA Damage Response","volume":"9","author":"Xuan","year":"2018","journal-title":"Cell Death Dis."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.ccr.2011.08.016","article-title":"FoxM1 Promotes \u03b2-Catenin Nuclear Localization and Controls Wnt Target-Gene Expression and Glioma Tumorigenesis","volume":"20","author":"Zhang","year":"2011","journal-title":"Cancer Cell"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"5658","DOI":"10.1158\/0008-5472.CAN-12-0953","article-title":"FoxM1 and Wnt\/\u03b2-Catenin signaling in Glioma Stem Cells","volume":"72","author":"Gong","year":"2012","journal-title":"Cancer Res."},{"key":"ref_49","first-page":"31","article-title":"WNT\/\u03b2-catenin Signaling Pathway and Downstream Modulators in Low- and High-grade Glioma","volume":"13","author":"Denysenko","year":"2016","journal-title":"Cancer Genom. Proteom."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/labinvest.2015.140","article-title":"WNT Signaling in Glioblastoma and Therapeutic Opportunities","volume":"96","author":"Lee","year":"2016","journal-title":"Lab. Investig. J. Tech. Methods Pathol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"22703","DOI":"10.18632\/oncotarget.25210","article-title":"Inhibition of Wnt\/beta-Catenin Signaling Downregulates Expression of Aldehyde Dehydrogenase Isoform 3A1 (ALDH3A1) to Reduce Resistance Against Temozolomide in Glioblastoma in Vitro","volume":"9","author":"Suwala","year":"2018","journal-title":"Oncotarget"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/s41419-020-02988-8","article-title":"Wnt\/\u03b2-Catenin Signaling Pathway Induces Autophagy-Mediated Temozolomide-Resistance in Human Glioblastoma","volume":"11","author":"Yun","year":"2020","journal-title":"Cell Death Dis."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1158\/0008-5472.CAN-09-3909","article-title":"FoxM1B Regulates NEDD4-1 Expression, Leading to Cellular Transformation and Full Malignant Phenotype in Immortalized Human Astrocytes","volume":"70","author":"Dai","year":"2010","journal-title":"Cancer Res."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Bielecka-Wajdman, A.M., Machnik, G., Linnebacher, C., Linnebacher, M., Stec-Grosman, K., and Obuchowicz, E. (2024). A Dot-Blot Screening for Identifying the Temozolomide-Regulated Proteins as Potential Targets for Glioma Multi-OMICS Studies. Front. Biosci., 29.","DOI":"10.31083\/j.fbl2910364"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s12935-026-04213-6","article-title":"Distinct Molecular Pathways Leading to Dosage-Dependent Temozolomide Resistance in GBM Stem Cells","volume":"26","author":"Marei","year":"2026","journal-title":"Cancer Cell Int."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"7494","DOI":"10.1038\/sj.onc.1208049","article-title":"Survivin Enhances Radiation Resistance in Primary Human Glioblastoma Cells via Caspase-Independent Mechanisms","volume":"23","author":"Chakravarti","year":"2004","journal-title":"Oncogene"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.tcb.2021.05.001","article-title":"Cyclin E in Normal Physiology and Disease States","volume":"31","author":"Chu","year":"2021","journal-title":"Trends Cell Biol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1002\/mc.23034","article-title":"Inhibition of Cyclin E1 Overcomes Temozolomide Resistance in Glioblastoma by Mcl-1 Degradation","volume":"58","author":"Liang","year":"2019","journal-title":"Mol. Carcinog."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/CAD.0000000000000700","article-title":"MicroRNA-195 Reverses the Resistance to Temozolomide Through Targeting Cyclin E1 in Glioma Cells","volume":"30","author":"Wang","year":"2019","journal-title":"Anticancer Drugs"}],"container-title":["Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-7737\/15\/16\/1371\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T08:29:26Z","timestamp":1786523366000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-7737\/15\/16\/1371"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,12]]},"references-count":59,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["biology15161371"],"URL":"https:\/\/doi.org\/10.3390\/biology15161371","relation":{},"ISSN":["2079-7737"],"issn-type":[{"value":"2079-7737","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,12]]}}}